Reata Pharmaceuticals Inc

ROYAL BANK OF CANADA

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

3,462

Value ($000)

353

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	353	0.0%	3,462	6/30/2023
2023 Q1	5/15/2023	177	0.0%	1,951	3/31/2023
2022 Q4	2/14/2023	178	0.0%	4,677	12/31/2022
2022 Q3	11/14/2022	20	0.0%	829	9/30/2022
2022 Q2	8/15/2022	9	0.0%	290	6/30/2022
2022 Q1	5/16/2022	56	0.0%	1,708	3/31/2022
2021 Q4	2/14/2022	148	0.0%	5,605	12/31/2021
2021 Q3	11/15/2021	305	0.0%	3,037	9/30/2021
2021 Q2	8/16/2021	271	0.0%	1,911	6/30/2021
2021 Q1	7/20/2021	1,462	0.0%	14,667	3/31/2021
2020 Q4	2/16/2021	53	0.0%	429	12/31/2020
2020 Q3	11/16/2020	22	0.0%	225	9/30/2020
2020 Q2	8/14/2020	2,040	0.0%	13,074	6/30/2020
2020 Q1	6/16/2020	1,016	0.0%	7,039	3/31/2020
2019 Q4	2/14/2020	98	0.0%	477	12/31/2019